The AhR binds to contain ligands, such as 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin, 3-methylcholantrene, or β-naphthoflavone. The activation mechanism of AhR
and the AhR-PAS or AhR-bHLH domain in vitro.
Cisplatin (cis-Diamineplatium (II) dichloride) is a widely used antineoplastic drug for clinical cures. Cisplatin possesses the ability to bind DNA and inhibits the replication of DNA, resulted in the inhibition of tumor cell growth. Previously, we found that cisplatin directly binds HSP90 and inhibits its aggregation prevention activity in vitro [3] . Cisplatin inhibits glucocorticoid receptor-dependent and androgen receptor-dependent transcriptional activities in a dose-dependent manner in human cultured cells [13] . Inhibition of the HSP90 functions by cisplatin is considered to occur in vivo as well as in vitro. There is no report against the influence of cisplatin to AhR-HSP90 complex. We investigated the influence of cisplatin on the association or dissociation of AhR from HSP90-cochaperone complex. 
Materials and Methods

Chemicals
17
Antibodies
An antibody against AhR and β-actin were from Thermo Fisher Scientific (catalogue no; MA1-513). The rabbit polyclonal antibodies against HSP90, XAP2, and p23 were previously described [3] [9] [10].
Cell Culture
The human cervical cancer cell line, HeLa cells were cultured in Dullbecco's modified Eagle's medium (DMEM; SIGMA) with 10% fetal bovine serum (Equitech-Bio), 20 μg/ml streptomycin, and 20 unit/ml penicillin (GIBCO) at 37˚C and 5% CO 2 . For MG132 treatment, 20,000 cells were plated in 96 well E-plate and their growth was monitored for 24 h. Cells were treated with 50 μM cisplatin for 16 hr and 50 μM of MG132 was added for 1 h and fresh media was added following washing once with media.
Cell Viability Assay
Cells were cultured in 96-well plates at a density of 2500 per well in 100 μl of medium 24 hrs before addition of cisplatin. Cisplatin was added in concentrations of 0 -100 μM. To assess cell viability, 10 μl of MTT solution (Thiazolyl Blue Tetrazolium Bromide (SIGMA) 5 mg/ml in PBS (phosphate buffered saline (-)) was added after a 16 hrs exposure to cisplatin. After a 4 h incubation, medium was removed and precipitates were lysed with 0.04 N HCl in 2-propanol. Then, absorbance was measured using a plate reader (Infinite F200, Tecan) at 595 nm.
Cell Treatment
HeLa cells were trypsinized and harvested in 35-mm dishes at a density of 1.5 × 10 5 cells, allowed to adhere for 24 hrs. Then, cells were treated by addition of 2 ml fresh DMEM containing samples at desired concentrations in DMSO. The cells were incubated in a certain time at 37˚C and 5% CO 2 .
Immunoblotting
Cells were rinsed three times with cold PBS, and collected using cell scraper (iwaki). The cell lysates were centrifuged at 2000 rpm at 4˚C for 5 min. The supernatants were removed and then lysed in lysis buffer (50 mM HEPES-NaOH, 5% Glycerol, 1% NP-40, 5 mM EDTA, 100 mM NaCl, 1 mM PMSF). After 10min incubation on ice, the lysates were centrifuged at 15,000 rpm at 4˚C for 15 min and then the supernatants were used. 
Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
Total RNA was isolated from cells using RNeasy Mini Kit (Qiagen). β-actin (forward, 5'-GCTCGTCGTCGACAACGGCTC-3'; reverse, 5'-CAAACA TGATCTGGGTCATCTTCTC-3'). The PCR products were separated in 1%
agarose gels and stained with ethidium bromide. The CYP1A1/β-actin ratio was quantified using Image J software (Drop of Wisdom).
Recombinant Protein Contract, Expression and Purification
The total RNA was isolated from the HeLa cells using the RNeasy Mini Kit 
GST Pull-Down Assay
For the GST pull-down assay, the concentration of ATP, 17-DMAG, and cisplatin were according to previous reports [9] [10]. 2.5 μM GST-bHLH or GSTAhR-ΔAD or GST protein was added to a solution of 2. All the GST pull-down samples were separated by and detected by Coomassie Brilliant Blue R-250 staining.
Results
Influence of Cisplatin on HeLa Cell Viability
We investigated the effect of cisplatin on the HeLa cell viability. In the present study, we did the evaluation using human epitheloid cervix carcinoma HeLa cells. The cell viability was reduced to about 70% in a cisplatin dependent manner (0 -250 μM) (Figure 1 ). We focused on 50 μM cisplatin in which the cell viability was about 80%.
Effects of Cisplatin on AhR and Chaperone Complex
We analyzed the effects of cisplatin (0 -50 μM) on the contents of AhR, HSP90, XAP2, and p23 in the cells. No changes were observed for the proteins contents of HSP90, XAP2, and p23 on immunoblotting (Figure 2(a) ). On the contrary, the contents of AhR were reduced at 50 μM cisplatin. At 50 μM cisplatin, about 80% of the AhR contents was reduced (Figure 2(b) ). We investigated the effects of MG132 (proteasome inhibitor) on the AhR contents in the presence of cisplatin. In the presence of 50 μM cisplatin, we could detect faintly AhR protein band in the absence of MG132. On the contrary, the AhR protein bands were clearly shown in the presence of 50 μM cisplatin and MG132 (Figure 2(c) ). Figure 1 . Effects of cisplatin on HeLa cell viability. HeLa cells were cultured in the presence or absence of cisplatin (5 -250 μM) for 16 hrs. The cell viability was measured using the MTT assay. The cell viability was about 80% at 50 μM cisplatin. In the present study, we used 50 μM of cisplatin. American Journal of Molecular Biology 
Effects of Cisplatin on AhR Activation
We next investigated CYP1A1 expression level. Cyp1A1 mRNA was analyzed by RT-PCR in the absence (Figure 3(a) ) or presence of 3MC (Figure 3(b) ) from 0 to 8 hrs. CYP1AI was increased from 2 hrs and the maximum occurred at 4 hr (Figure 3(b) ). We next analyzed the influence of cisplatin on the CYP1A1 expression. In the presence of 3MC, the indicated cisplatin was added to the HeLa cells and the CYP1A1 mRNA was analyzed by RT-PCR and agarose gel electrophoresis ( Figure 3(c) ). The CYP1A1/β-actin ratio based on Figure 3 (c) was quantified. At 50 μM cisplatin, the CYP1A mRNA level was low until about 20%
( Figure 3(d) ).
Influence of ATP, Cisplatin, and 17-DMAG on AhR-HSP90 Complex
We investigated the GST pull-down assay using GST-bHLH and HSP90. GST pull-down assay was performed in the presence or absence of 50 μM cisplatin, 50 bHLH and HSP90. The HSP90 contents were also the same as the control (no ATP, cisplatin, and 17-DMAG). On the contrary, the bHLH bound HSP90 was less than that of HSP90. In the presence of cisplatin, no effects were observed during the association or dissociation of bHLH and HSP90. Based on the GSTbHLH-HSP90 pull-down assay, there were no effects of ATP or 17-DMAG, and ATP/17-DMAG on the GST bHLH-HSP90 association or dissociation ( Figure   4 (a), right panels). Next, we confirmed the influence of the ligand on the AhR-HSP90 complex using GST-AhR-ΔAD. AhR-ΔAD is near the full length of AhR (deletion of transactivation domain). As shown in Figure 4 (b), no changes in the GST-AhR-ΔAD and HSP90 ratio in the absence or presence of 3MC were observed. As shown in Figure 4 (c), GST-AhR-ΔAD could bind to HSP90 in the presence of 3MC. ATP had no effect on the ratio of GST-AhR-ΔAD and HSP90. 
Discussion
It has been reported that AhR is composed of three domains (b-HLH, PAS, and TAD; transactivation domains) [14] [15] [16] . AhR forms a complex with the molecular chaperone HSP90, co-chaperone p23, and the hepatitis B virus X-associated protein XAP2 in the cytoplasm [14] [15] [16] . The molecular chaperone HSP90 regulates the physiological functions of more than 300 proteins including the steroid hormone receptors in the cells [1] [2] . We reported the activation mechanisms of AHR by HSP90 [9] . We also reported that AhR binds to the HSP90 N-domain [10] . We speculated that the bHLH binding site of the HSP90 N-domain may be the neighbor of the M-domain. On the contrary, the PAS binding site of the HSP90 N-domain may be the end of the N-domain.
In the present study, we investigated the influence of cisplatin on the AhR activation. We reported that cisplatin binds to HSP90 and inhibits HSP90 chaperone activity [3] [4] . Cisplatin binds to the HSP90 C-domain following the N-domain. The AhR contents in the HeLa cells were strongly reduced in the presence of 50 μM cisplatin at 16 hrs after addition of the drug. However, we could detect AhR in the presence of MG132 during immunoblotting. AhR plays the role as a transcription factor in the nuclei and induces CYP1A1 [17] . In the presence of 50 μM cisplatin, the CYP1A1 mRNA level was strongly reduced.
These results suggested that AhR was dissociated from the HSP90 chaperone complex when in the presence of cisplatin. AhR is a very unstable protein, thus the released unstable AhR will be degraded through the 26S proteasome.
It is difficult to purify the full length AhR because of its unstability. The E. Sasaki-Kudoh et al.
